Publication | Closed Access

Nicotinamide mononucleotide ameliorates DNFB-induced atopic dermatitis-like symptoms in mice by blocking activation of ROS-mediated JAK2/STAT5 signaling pathway

InflammationRos-mediated Jak2/stat5Nicotinamide MononucleotideAtopic DermatitisImmunologyAutoimmunityDermatologyMedicineCell SignalingHypersensitivityJak-stat Signaling Pathway